Page last updated: 2024-10-24

carteolol and Lymphoma

carteolol has been researched along with Lymphoma in 1 studies

Carteolol: A beta-adrenergic antagonist used as an anti-arrhythmia agent, an anti-angina agent, an antihypertensive agent, and an antiglaucoma agent.

Lymphoma: A general term for various neoplastic diseases of the lymphoid tissue.

Research Excerpts

ExcerptRelevanceReference
"We have tested the effects of carteolol and 8-hydroxycarteolol on cAMP generation in S49 lymphoma and BC3H1 smooth muscle-like cells."3.68The beta-adrenoceptor antagonist carteolol and its metabolite 8-hydroxycarteolol have different intrinsic sympathomimetic activities. ( Insel, PA; Jasper, JR; Michel, MC, 1990)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Jasper, JR1
Michel, MC1
Insel, PA1

Other Studies

1 other study available for carteolol and Lymphoma

ArticleYear
The beta-adrenoceptor antagonist carteolol and its metabolite 8-hydroxycarteolol have different intrinsic sympathomimetic activities.
    British journal of clinical pharmacology, 1990, Volume: 30 Suppl 1

    Topics: Carteolol; Cyclic AMP; Humans; Isoproterenol; Lymphoma; Muscle, Smooth; Sympathomimetics; Tumor Cell

1990